Opendata, web and dolomites

SmartHeart SIGNED

SmartHeart, a 3D in vitro assay for improved assessment of cardiac drug efficacy and toxicity

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SmartHeart project word cloud

Explore the words cloud of the SmartHeart project. It provides you a very rough idea of what is the project "SmartHeart" about.

cros    3dcell    contractility    acquired    animal    tune    cardiac    drug       retrieve    shortcomings    cells    pluripotent    cms    multiwell    cardiomyocytes    resolution    meet    qualitative    body    stage    clinical    competences    feedback    managerial    4dcell    drugs    hts    transients    simultaneously    plates    specifications    academic    gel    industrial    currently    cultured    imaging    expertise    3d    structure    final    fine    maturation    read    limiting    maturity    answer    hcs    candidate    put    diseases    whom    compatible    pharma    microstructured    angle    cellular    stem    trials    calcium    standards    assays    entering    screening    models    quantitative    human    observation    technological    predict    device    leader    efficient    closer    ultimate    vitro    commercial    physics    er    mimic    commercialized    outs    platforms    minimized    career    act    culture    nature    action    assay    smartheart    sub    proprietary    techniques    ethical   

Project "SmartHeart" data sheet

The following table provides information about the project.

Coordinator
4DCELL 

Organization address
address: 14 RUE DE LA BEAUNE BAT C ETAGE 2
city: MONTREUIL
postcode: 93100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 196˙707 €
 EC max contribution 196˙707 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2019
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2020
 Duration (year-month-day) from 2020-03-02   to  2022-03-01

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    4DCELL FR (MONTREUIL) coordinator 196˙707.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

Currently, animal models are still widely used in the pre-clinical stage of drug development to mimic human diseases or predict the human body’s response to candidate drugs. However, their use should be minimized as much as possible due to ethical issues and since only 9.6% of drugs entering phase I of clinical trials end up being commercialized. Therefore, the goal of this action is to develop a novel proprietary 3D in vitro cardiac assay. The SmartHeart will retrieve several of the most important read-outs commonly assessed to study the impact of drugs at the cardiac level in the pre-clinical phase. The all in one assay will be based on a microstructured gel where cardiac cells, as cardiomyocytes derived from induced pluripotent stem cells will be cultured. The SmartHeart will answer to the shortcomings of academic and commercial available in vitro assays, by enabling the qualitative and quantitative measurement of several parameters, as contractility and Calcium transients. Simultaneously, the assay will enable sub-cellular structure observation via high-resolution imaging techniques. Furthermore, the 3D nature of the assay will contribute to the efficient maturation of the induced CMs, which is still a limiting factor when not using cardiac human cells, but rather induced CMs, in in vitro assays. The ultimate aim of the project is to make this device available to screening platforms, e.g. Pharma or CROs. The technology will be implemented in multiwell plates compatible with the standards of HTS/HCS and will be available to early-users, from whom feedback will be acquired, enabling to fine tune the specifications of the final device. This project will meet the best of the ER competences in physics, with the expertise of 4Dcell in 3Dcell culture systems. With this project, the ER will reach a level of maturity on several technological, managerial and industrial aspects providing her a new career angle and put her a step closer to act as a leader in research.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SMARTHEART" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SMARTHEART" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

TCFLAND2SEA (2020)

Thawing Carbon From LAND to SEA: Microbial Degradation of Organic Matter and Response to Thawing Permafrost in the Northeast Siberian Land-Shelf System

Read More  

TheaTheor (2018)

Theorizing the Production of 'Comedia Nueva': The Process of Play Configuration in Spanish Golden Age Theater

Read More  

EVOMET (2019)

The rise and fall of metastatic clones under immune attack

Read More